EUVIMEDEUVIMED entdecken
Klinische Studie (Phase III)VergleichsstudieÄquivalenzstudieMultizentrische StudieOpen Access

Microultrasonography-Guided vs MRI-Guided Biopsy for Prostate Cancer Diagnosis

Adam Kinnaird, Ferdinand Luger, Hannes Cash, Sangeet Ghai, L Felipe Urdaneta-Salegui, Christian P Pavlovich, Joseph Brito, Neal D Shore, Julian P Struck, Martin Schostak, Niklas Harland, Moisés Rodriguez-Socarrás und 16 weitere

JAMA · 20.05.2025 · 333 (19) · 1679

DOI: 10.1001/jama.2025.3579 ↗

Kurz gefasst

Klinische Studie (Phase III) in der Zeitschrift JAMA, erschienen am 20.05.2025. Verfasst von Adam Kinnaird und 27 weiteren Autor:innen. Beteiligte Einrichtung: Division of Urology, Departments of Surgery and Oncology, University of Alberta, Edmonton, Canada. Hauptthemen laut MEDLINE: Image-Guided Biopsy, Magnetic Resonance Imaging, Interventional, Prostate, Prostatic Neoplasms. Die Arbeit wurde bisher 94-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance High-resolution microultrasonography-guided biopsy is an alternative to MRI fusion-guided biopsy for prostate cancer diagnosis.

Objective

To compare microultrasonography-guided and MRI fusion-guided biopsy. Design, Setting, and Participants A multicenter, international, open-label, randomized, noninferiority trial of biopsy-naive men from 20 centers (8 countries) with clinical suspicion of prostate cancer (elevated prostate-specific antigen [PSA] and/or abnormal digital rectal examination findings) from December 2021 to September 2024.

Interventions

Participants were assigned to receive either microultrasonography-guided biopsy (n = 121), microultrasonography/MRI fusion-guided biopsy (microultrasonography/MRI; n = 226, in which microultrasonography biopsies were performed prior to unblinding the MRI), or MRI/conventional US fusion-guided biopsy (MRI/conventional ultrasonography; n = 331). All participants received synchronous systematic biopsy. Main Outcomes and Measures The primary outcome was the difference in detection of Gleason Grade Group 2 or higher cancers using microultrasonography plus systematic biopsy vs MRI/conventional ultrasonography plus systematic biopsy. The secondary outcome was the difference in detection of Gleason Grade Group 2 or higher cancers found using microultrasonography/MRI plus systematic biopsy vs MRI/conventional ultrasonography plus systematic biopsy. The noninferiority margin was set at 10%.

Results

A total of 802 men underwent randomization and 678 underwent biopsy. Median (IQR) age was 65 (59-70) years and prostate-specific antigen level was 6.9 (5.2-9.8) ng/mL; 83% self-identified as White. Gleason Grade Group 2 or higher cancer was detected in 57 participants (47.1%) in the microultrasonography group, in 141 (42.6%) in the MRI/conventional ultrasonography group, and in 106 (46.9%) in the microultrasonography/MRI group. Microultrasonography-guided biopsy was noninferior to MRI fusion-guided biopsy (difference, 3.52% [95% CI, −3.95% to 10.92%]; noninferiority P < .001). Combined biopsy with microultrasonography/MRI was also noninferior to MRI/conventional ultrasonography software-assisted MRI fusion biopsy using conventional ultrasonography devices (difference, 4.29% [95% CI, −4.06% to 12.63%]; noninferiority P < .001). The rate of Gleason Grade Group 2 or higher cancer diagnosed by targeted biopsy only was 38.0% in the microultrasonography group, 34.1% in the MRI/conventional ultrasonography group, and 40.3% in the microultrasonography/MRI group; these differences were not significant. Conclusions and Relevance The use of microultrasonography-guided biopsy was noninferior to MRI/conventional ultrasonography fusion-guided biopsy for the detection of Gleason Grade Group 2 or higher prostate cancer in biopsy-naive men. Microultrasonography may provide an alternative to MRI for image-guided prostate biopsy. Trial Registration ClinicalTrials.gov Identifier: NCT05220501

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Image-Guided BiopsyMagnetic Resonance Imaging, InterventionalProstateProstatic NeoplasmsUltrasonography, InterventionalAgedHumansMaleMiddle AgedProstate-Specific AntigenDigital Rectal ExaminationMultimodal ImagingNeoplasm Grading

Substanzen

Prostate-Specific Antigen

Autor:innen und Institutionen

  • Division of Urology, Departments of Surgery and Oncology, University of Alberta, Edmonton, Canada.
  • Department of Urology, Ordensklinikum Linz Elisabethinen, Austria.
  • PROURO, Berlin, Germany.
  • Department of Urology, University Clinic for Urology, Urooncology, Robot-assisted and Focal Therapy, University Clinic of Magdeburg, Germany.
  • University Medical Imaging Toronto, Joint Department of Medical Imaging, University Health Network-Mount Sinai Hospital-Women's College Hospital, University of Toronto, Toronto General Hospital, Toronto, Canada.
  • Urología Clínica Bilbao. Clínica IMQ Zorrotzaurre. Bilbao, Spain.

Zitieren

APA

Kinnaird, A., Luger, F., Cash, H., Ghai, S., Urdaneta-Salegui, L. F., Pavlovich, C. P., Brito, J., Shore, N. D., Struck, J. P., Schostak, M., Harland, N., Rodriguez-Socarrás, M., Brisbane, W. G., Lughezzani, G., Toledano, H., Ouertani, M. S., Macek, P., Fung, C., Tu, W., …, & OPTIMUM Investigators (2025). Microultrasonography-Guided vs MRI-Guided Biopsy for Prostate Cancer Diagnosis. JAMA, 333(19), 1679. https://doi.org/10.1001/jama.2025.3579

Vancouver

Kinnaird A, Luger F, Cash H, Ghai S, Urdaneta-Salegui LF, Pavlovich CP, et al. Microultrasonography-Guided vs MRI-Guided Biopsy for Prostate Cancer Diagnosis. JAMA. 2025;333(19):1679. doi:10.1001/jama.2025.3579

BibTeX
@article{Kinnaird2025,
  author = {Kinnaird, Adam and Luger, Ferdinand and Cash, Hannes and Ghai, Sangeet and Urdaneta-Salegui, L Felipe and Pavlovich, Christian P and Brito, Joseph and Shore, Neal D and Struck, Julian P and Schostak, Martin and Harland, Niklas and Rodriguez-Socarrás, Moisés and Brisbane, Wayne G and Lughezzani, Giovanni and Toledano, Harry and Ouertani, Mohammed Salah and Macek, Petr and Fung, Christopher and Tu, Wendy and Gusenleitner, Andreas and Günzel, Karsten and Incze, Peter F and George, Arvin K and Pereira, José G and Jansen, Robert and Renzulli, Joseph and Klotz, Laurence and OPTIMUM Investigators, OPTIMUM Investigators},
  title = {Microultrasonography-Guided vs MRI-Guided Biopsy for Prostate Cancer Diagnosis},
  journal = {JAMA},
  year = {2025},
  volume = {333},
  number = {19},
  pages = {1679},
  doi = {10.1001/jama.2025.3579}
}
Kostenlos starten →